All posts by Iain Wilkie
Research Analyst
Sectors Covered: Healthcare and Life Sciences
By Iain Wilkie
01 October 2021, 8:30 AM
Pro Medicus (ASX:PME) has announced the signing of US-based Novant Health on a 7-year A$40m contract for the workflow and viewer products.
Read more...
By Iain Wilkie
19 August 2021, 10:00 AM
Pro Medicus (ASX:PME) recorded another year of strong growth across all metrics although lower than our forecasts and consensus expectations.
Read more...
By Iain Wilkie
30 March 2021, 4:00 PM
Morgans analyst Iain Wilkie speaks with Chief Executive Officer and Managing Director of ResApp (ASX:RAP), Tony Keating. Tony provides an update on a number of recent news events.
Read more...
By Iain Wilkie
17 November 2020, 11:00 AM
Morgans analyst Iain Wilkie chats to Dr Sean Hall who is the CEO and MD of drug development company Medlab Clinical (ASX:MDC) on some recent news and upcoming catalysts.
Read more...